Larotrectinib Sulfate LOXO-101 1223405-08-0
- EINECS No
- 232-655-5
- Shelf Life
- 2 Years
- Storage
- Room Temperature
- Taste
- Odorless
- Smell
- No Smell
- Molecular Formula
- C21H22F2N6O2.H2SO4
- Structural Formula
- C21H22F2N6O2.H2SO4
- Medicine Name
- LOXO-101 (sulfate)
- Chemical Name
- (3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate (1:1)
- CAS No
- 1223405-08-0
- Type
- Pharmaceutical Intermediates
- Grade
- Medicine Grade
- Usage
- human
- Purity(%)
- 99
- Appearance
- white powder
- Physical Form
- Powder
Larotrectinib Sulfate is the first drug specifically developed and approved to treat any cancer that contains certain mutations. It is an inhibitor of the tropomyosin kinase receptors TrkA, TrkB, and TrkC.
Product Name | Larotrectinib sulfate |
Synonyms | LOXO-101 (sulfate);(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate (1:1);Larotrectinib/LOXO 101/ARRY 470 sulfate;(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate;ARRY 470) sulfate;Larotrectinib sulfate;Larotrectinib(LOXO 101;Larotrectinib (LOXO-101) sulfate |
CAS | 1223405-08-0 |
MF | C21H24F2N6O6S |
MW | 526.5136664 |
EINECS | N/A |
Product Categories | Inhibitor;API |
Mol File | 1223405-08-0.mol |
- FOB Port
- shanghai
- Payment Terms
- Cash Against Delivery (CAD), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Paypal
- Supply Ability
- 100 Per Week
- Delivery Time
- 5 Days
- Sample Policy
- If order is confirmed we will reimburse the sample cost
- Packaging Details
- Double PE with aluminium foil bag
- Main Export Market(s)
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- Main Domestic Market
- All India
- Certifications
- ISO9001